Holly May

Holly is a rare diseases leader with deep experience in commercial strategy and operations. She was previously vice president and head of commercial at SOBI, Inc., where she led all aspects of commercial strategy, operations and performance. Prior to joining SOBI, Holly held leadership roles of increasing strategic importance across marketing, operations, sales, and strategic planning at Sanofi and Genzyme. As vice president in the Genzyme rare disease unit, she led the team responsible for brand, disease and digital marketing for Fabry and other lysosomal disorders. She holds a bachelor’s degree in zoology from Miami University of Ohio, and an MBA with a concentration in marketing from the University of Akron.

Holly May is the Chief Commercial Officer at BiolineRx, based in United States, North America. With a background in Biotechnology, Holly May has a rich history of leadership and innovation.Holly May studied MBA Marketing at The University of Akron. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.